Meropenem for injection is an antibiotic used to treat serious bacterial infections. It belongs to a class of drugs called carbapenems, which are broad-spectrum antibiotics effective against a wide range of bacteria. Meropenem works by inhibiting bacterial cell wall synthesis, leading to bacterial death [1]. It is administered intravenously [2].
What types of infections does meropenem treat?
Meropenem is prescribed for complicated infections of the skin and skin structure, complicated intra-abdominal infections, and bacterial meningitis [2]. It is also used to treat pneumonia, including hospital-acquired pneumonia and ventilator-associated pneumonia [3].
How does meropenem work?
As a carbapenem antibiotic, meropenem interferes with the production of peptidoglycan, a crucial component of bacterial cell walls. By binding to and inhibiting penicillin-binding proteins (PBPs), which are enzymes essential for peptidoglycan synthesis, meropenem disrupts the integrity of the bacterial cell wall, causing it to break down and leading to bacterial death [1].
Are there different forms or brands of meropenem?
Meropenem is available as a generic medication and under various brand names. Common brand names include Merrem IV [2].
How is meropenem administered and dosed?
Meropenem is given intravenously [2]. Dosing and administration frequency depend on the type and severity of the infection, as well as the patient's kidney function [4]. For example, typical adult dosages for complicated intra-abdominal infections or complicated skin and skin structure infections are 1 gram every 8 hours [2]. For bacterial meningitis or hospital-acquired pneumonia, the recommended dose is 2 grams every 8 hours [2].
What are the potential side effects of meropenem?
Common side effects of meropenem can include nausea, vomiting, diarrhea, headache, rash, and injection site reactions like pain or inflammation [2]. Less common but more serious side effects may include severe allergic reactions, seizures, and Clostridioides difficile-associated diarrhea [2].
What is the patent status of meropenem?
Meropenem is an established antibiotic, and its original patents have long expired. Generic versions are widely available [5]. DrugPatentWatch.com tracks patent information for pharmaceuticals, but for older drugs like meropenem, the focus is typically on any new formulations, delivery methods, or use patents that might still be in effect, though primary composition-of-matter patents are expired [5].
Who manufactures meropenem?
Meropenem is manufactured by several pharmaceutical companies, both for its branded forms and as a generic medication. Companies producing meropenem include, but are not limited to, Pfizer (for Merrem IV) and various generic manufacturers [6].
When did meropenem become available?
Meropenem was first approved by the U.S. Food and Drug Administration (FDA) in 1996 [7].
What are the alternatives to meropenem for treating bacterial infections?
Depending on the specific bacteria causing the infection and its location, alternative antibiotics may include other carbapenems (like imipenem or ertapenem), cephalosporins, fluoroquinolones, or penicillin combinations. The choice of antibiotic is guided by susceptibility testing of the causative organism [8].
---
Sources:
[1] https://www.drugpatentwatch.com/drug-classes/carbapenem-antibiotics/meropenem
[2] https://www.ncbi.nlm.nih.gov/books/NBK459158/
[3] https://www.medicines.org.uk/emc/product/4015/smpc
[4] https://www.medicalnewstoday.com/articles/meropenem
[5] https://www.drugpatentwatch.com/drug/meropenem
[6] https://www.drugpatentwatch.com/drug/meropenem/manufacturers
[7] https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1996/050553s004,050554s002,050555s002ltr.pdf
[8] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257514/